Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Case

Showing results (231-240 of 252) with videos related to

Pageof 26
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1996
Phase I study of N-(phosphonacetyl)-L-aspartate with fluorouracil and with or without dipyridamole in patients with advanced cancerR A Fleming, R L Capizzi, H B Muss, et al.
BMC Medical Genetics|October 25, 2008
Multiple interactions between the alpha 2C- and beta1-adrenergic receptors influence heart failure survivalSharon L R Kardia, Reagan J Kelly, Mehdi A Keddache, et al.
Thrombosis Research|February 18, 2004
Administration of a small molecule tissue factor/factor VIIa inhibitor in a non-human primate thrombosis model of venous thrombosis: effects on thrombus formation and bleeding timeJames A Szalony, Osman D Suleymanov, Anita K Salyers, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2009
Piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregationJohn J Parlow, Mary W Burney, Brenda L Case, et al.
Bioorganic & Medicinal Chemistry Letters|October 3, 2009
Piperazinyl-glutamate-pyrimidines as potent P2Y12 antagonists for inhibition of platelet aggregationJohn J Parlow, Mary W Burney, Brenda L Case, et al.
Nucleic Acids Research|November 7, 2013
Co-transcriptional production of RNA-DNA hybrids for simultaneous release of multiple split functionalitiesKirill A Afonin, Ravi Desai, Mathias Viard, et al.
Biochimica Et Biophysica Acta|December 4, 2010
Receptor protein tyrosine phosphatases are novel components of a polycystin complexCatherine A Boucher, Heather H Ward, Ruth L Case, et al.
Bioorganic & Medicinal Chemistry Letters|January 26, 2010
Part II: piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregationJohn J Parlow, Mary W Burney, Brenda L Case, et al.
Journal of Medicinal Chemistry|February 10, 2010
Piperazinyl glutamate pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregationJohn J Parlow, Mary W Burney, Brenda L Case, et al.
Molecular Phylogenetics and Evolution|July 16, 2025
Population-level phylogenomic analysis yields insights into species cohesion and population substructure of Lobelia section Lobelia (Campanulaceae)Grant T Godden, Andrew A Crowl, Stephen R Patten, et al.
Pageof 26

Showing results (231-240 of 252) with videos related to

Sort By:
Pageof 26
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1996
Phase I study of N-(phosphonacetyl)-L-aspartate with fluorouracil and with or without dipyridamole in patients with advanced cancerR A Fleming, R L Capizzi, H B Muss, et al.
BMC Medical Genetics|October 25, 2008
Multiple interactions between the alpha 2C- and beta1-adrenergic receptors influence heart failure survivalSharon L R Kardia, Reagan J Kelly, Mehdi A Keddache, et al.
Thrombosis Research|February 18, 2004
Administration of a small molecule tissue factor/factor VIIa inhibitor in a non-human primate thrombosis model of venous thrombosis: effects on thrombus formation and bleeding timeJames A Szalony, Osman D Suleymanov, Anita K Salyers, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2009
Piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregationJohn J Parlow, Mary W Burney, Brenda L Case, et al.
Bioorganic & Medicinal Chemistry Letters|October 3, 2009
Piperazinyl-glutamate-pyrimidines as potent P2Y12 antagonists for inhibition of platelet aggregationJohn J Parlow, Mary W Burney, Brenda L Case, et al.
Nucleic Acids Research|November 7, 2013
Co-transcriptional production of RNA-DNA hybrids for simultaneous release of multiple split functionalitiesKirill A Afonin, Ravi Desai, Mathias Viard, et al.
Biochimica Et Biophysica Acta|December 4, 2010
Receptor protein tyrosine phosphatases are novel components of a polycystin complexCatherine A Boucher, Heather H Ward, Ruth L Case, et al.
Bioorganic & Medicinal Chemistry Letters|January 26, 2010
Part II: piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregationJohn J Parlow, Mary W Burney, Brenda L Case, et al.
Journal of Medicinal Chemistry|February 10, 2010
Piperazinyl glutamate pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregationJohn J Parlow, Mary W Burney, Brenda L Case, et al.
Molecular Phylogenetics and Evolution|July 16, 2025
Population-level phylogenomic analysis yields insights into species cohesion and population substructure of Lobelia section Lobelia (Campanulaceae)Grant T Godden, Andrew A Crowl, Stephen R Patten, et al.
Pageof 26